A family of cAMP-binding proteins that directly activate Rap1.
暂无分享,去创建一个
A M Graybiel | A. Graybiel | D. Housman | M. Matsuda | N. Mochizuki | D E Housman | H Kawasaki | G M Springett | N Mochizuki | S Toki | M Nakaya | M Matsuda | M. Nakaya | G. Springett | S. Toki | N. Mochizuki | H. Kawasaki
[1] G. Ellison. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula , 1994, Brain Research Reviews.
[2] K. Reymann,et al. Protein kinase A inhibitors prevent the maintenance of hippocampal long-term potentiation. , 1993, Neuroreport.
[3] T. Steitz,et al. Predicted structures of cAMP binding domains of type I and II regulatory subunits of cAMP-dependent protein kinase. , 1990, Biochemistry.
[4] Ravi Iyengar. Gating by Cyclic AMP: Expanded Role for an Old Signaling Pathway , 1996, Science.
[5] S. M. Van Patten,et al. Multiple pathway signal tran sduction by the cAMP‐dependent protein kinase , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] E. Kandel,et al. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. , 1993, Science.
[7] A. Graybiel,et al. Dopaminergic regulation of transcription factor expression in organotypic cultures of developing striatum , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] H. Kitayama,et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G , 1995, Molecular and cellular biology.
[9] H. Kitayama,et al. A ras-related gene with transformation suppressor activity , 1989, Cell.
[10] Robert C. Malenka,et al. Synaptic plasticity in the hippocampus: LTP and LTD , 1994, Cell.
[11] J. Bos,et al. Regulation of Ras-mediated signalling: more than one way to skin a cat. , 1995, Trends in biochemical sciences.
[12] E R Kandel,et al. Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RI beta subunit of cAMP-dependent protein kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] Jennifer A. Mangels,et al. A Neostriatal Habit Learning System in Humans , 1996, Science.
[14] R. Nicoll,et al. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. , 1994, Science.
[15] E. Kandel,et al. A genetic test of the effects of mutations in PKA on mossy fiber ltp and its relation to spatial and contextual learning , 1995, Cell.
[16] E R Kandel,et al. Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Bos,et al. In search of a function for the Ras‐like GTPase Rap1 , 1997, FEBS letters.
[18] H. Fibiger,et al. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[19] G. Shepherd,et al. Cyclic nucleotide gated channels as regulators of CNS development and plasticity , 1997, Current Opinion in Neurobiology.
[20] J. Bos,et al. cAMP antagonizes p21ras‐directed activation of extracellular signal‐regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. , 1993, The EMBO journal.
[21] M. Levine,et al. Protein kinase A is a common negative regulator of Hedgehog signaling in the vertebrate embryo. , 1996, Genes & development.
[22] R. Idzerda,et al. PKA isoforms, neural pathways, and behaviour: making the connection , 1997, Current Opinion in Neurobiology.
[23] E. Kandel,et al. Long-lasting forms of synaptic potentiation in the mammalian hippocampus. , 1996, Learning & memory.
[24] M. Hagiwara,et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.
[25] A. Pardee,et al. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.
[26] S. Taylor,et al. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. , 1988, The Journal of biological chemistry.
[27] J. Corbin,et al. Cyclic nucleotide-binding domains in proteins having diverse functions. , 1992, The Journal of biological chemistry.
[28] D. Øgreid,et al. Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase. , 1988, The Journal of biological chemistry.
[29] A. Graybiel,et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Krebs,et al. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Hill,et al. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. , 1998, Trends in pharmacological sciences.
[32] E. Kandel,et al. Toward a molecular definition of long-term memory storage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[34] S. Cook,et al. Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.
[35] J. Bos,et al. Rapid Ca2+‐mediated activation of Rap1 in human platelets , 1997, The EMBO journal.
[36] E. London,et al. Distribution of cerebral metabolic effects of nicotine in the rat. , 1985, European journal of pharmacology.
[37] E. Krebs,et al. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. , 1968, The Journal of biological chemistry.
[38] J. Ehrhardt,et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. , 1994, Science.
[39] Amtliches Mitteilungsblatt,et al. August , 1890, The Hospital.
[40] Eric R Kandel,et al. Identification of a Gene Encoding a Hyperpolarization-Activated Pacemaker Channel of Brain , 1998, Cell.
[41] S. Beebe,et al. The cAMP-dependent protein kinases and cAMP signal transduction. , 1994, Seminars in cancer biology.
[42] Y. Hata,et al. Enhancement of the actions of smg p21 GDP/GTP exchange protein by the protein kinase A-catalyzed phosphorylation of smg p21. , 1991, The Journal of biological chemistry.
[43] E. Mccleskey,et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.
[44] Susan S. Taylor,et al. cAMP-dependent protein kinase. Model for an enzyme family. , 1989, The Journal of biological chemistry.
[45] J. Stone,et al. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. , 1998, Science.
[46] R. Sandyk,et al. Relevance of the habenular complex to neuropsychiatry: a review and hypothesis. , 1991, The International journal of neuroscience.
[47] E. Sutherland,et al. Studies on the mechanism of hormone action. , 1972, Science.
[48] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[49] H. Yao,et al. cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.
[50] H. Yamamura,et al. Phosphorylation by cyclic AMP-dependent protein kinase of a human platelet Mr 22,000 GTP-binding protein (smg p21) having the same putative effector domain as the ras gene products. , 1988, Biochemical and biophysical research communications.